Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Risk adjusted net present value: What is the current valuation of Ionis Pharmaceuticals's Evazarsen Sodium?
Evazarsen Sodium is an antisense oligonucleotide commercialized by Ionis Pharmaceuticals, with a leading Phase II program in Resistant Hypertension. According...